The Stryker hip implant recall set off a flurry of lawsuits against the company as well as causing considerable amount of worry among the recipients of the recalled hip implants. Both the Rejuvenate and the ABGII were recalled in July, 2012 after a significant number of patients developed serious health symptoms following their Stryker implant surgery.

 

As one more in a long line of metal-on-metal hip implants to be plagued with recipient problems, the Biomet M2A Magnum first became available in October of 2004. The design of the Biomet M2A was meant to maximize mobility, minimize friction and offer a variety of size ranges to allow surgeons to more precisely fit the implant to the specific anatomy of each patient. Unfortunately, Biomet’s design has been found to have many of the same risks as other metal-on-metal hip implants such as metallosis, nerve and tissue damage in the area surrounding the implant, bone loss and loosening of the device which contributes to hip dislocation.

Like many other metal-on-metal hip implant manufacturers, Wright Medical Technology has experienced problems with its Profemur and the Wright-Conserve Total Hip System, including metallosis and metal toxicity among recipients.

Each day in the United States hundreds of people enter hospitals to undergo surgical procedures. Replacement hip surgery has become much more common among older Americans who want to continue to live an active lifestyle. In fact, there are over 400,000 hip replacement surgeries performed every year. Hip implants made their first appearance in the 1970’s, and these implants were made of a combination of materials, including plastics, ceramics and metals. The metal-on-metal hip implants were created in the hopes of giving patients more durability and years of wear from their hip implant.